<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head>
  <title>Sarath Kanekal - LinkedIn </title>
  <meta http-equiv="content-type" content="text/html; charset=UTF-8" />
  <link href="http://www.linkedin.com/favicon.ico" rel="shortcut icon" type="image/ico"></link>
  
    <meta name="description" content="View Sarath Kanekal's professional profile on LinkedIn.  LinkedIn is the world's largest business network, helping professionals like Sarath Kanekal discover inside connections to recommended job candidates, industry experts, and business partners." />
  
      <link rel="stylesheet" type="text/css" href="http://static.linkedin.com/scds/pprofile/build-502_6_2523-prod/css/public-profile/default.css">
    
</head>
<body id="www-linkedin-com" class="en public-profile">

<script type="text/javascript">document.body.className += " js";</script>
  
<div class="hresume">
    <div class="profile-header">
      <div class="masthead vcard contact">
        <div id="nameplate">
          <h1 id="name"><span class="fn n"><span class="given-name">Sarath</span> <span class="family-name">Kanekal</span></span></h1>
        </div>
        <div class="content">
          <div class="info">
              <p class="headline title">
                
      President at WWW.TOX-CONSULTANT.COM
    
              </p>
            <div class="adr">
              <p class="locality">
                
      Greater San Diego Area
    
              </p>
            </div>
          </div>
          <div class="actions">
            <ul>
              <li id="send-inmail">
                <a href="http://www.linkedin.com/ppl/webprofile?action=ctu&amp;id=13897601&amp;pvs=pp&amp;authToken=iHvk&amp;authType=name&amp;trk=ppro_cntdir&amp;lnk=cnt_dir" rel="nofollow">Contact Sarath Kanekal</a>
              </li>
              <li id="add-to-network">
                <a href="http://www.linkedin.com/ppl/webprofile?action=ctu&amp;id=13897601&amp;pvs=pp&amp;authToken=iHvk&amp;authType=name&amp;trk=ppro_getintr&amp;lnk=cnt_dir" rel="nofollow">Add Sarath Kanekal to your network</a>
              </li>
            </ul>
          </div>
        </div>
      </div>
    </div>
  <div id="main">
        <div id="overview">
          <dl>
              <dt>Current</dt>
              <dd>
                <ul class="current">
                        <li>




            
      President
    
 at WWW.TOX-CONSULTANT.COM

                        </li>
                </ul>
              </dd>
              <dt>Past</dt>
              <dd>
                <ul>
                        <li>




            
      Executive Director, Preclinical Development
    
        at
            <a href="http://www.linkedin.com/companies/supergen" >SuperGen</a>

                        </li>
                        <li>




            
      Consultant, Nonclinical
    
 at Chemgenex Inc

                        </li>
                        <li>




            
      Toxicology PK consultant
    
        at
            <a href="http://www.linkedin.com/companies/supergen" >SuperGen</a>

                        </li>
                </ul>
                  <div class="showhide-block" id="morepast">
                    <ul>
                            <li>




            
      Associate Director, Drug Assesment &amp; Development
    
 at Chiron (Novartis)

                            </li>
                            <li>




            
      Senior Director, Pharmacology &amp; Toxicology
    
 at Salmedix Inc (Cephalon)

                            </li>
                            <li>




            
      Director Drug Safety
    
 at Corixa

                            </li>
                            <li>




            
      Assoc Director, Tox/PK
    
 at Matrix Pharmaceuticals

                            </li>
                    </ul>
                    <p class="seeall showhide-link"><a href="#" id="morepast-hide">see less...</a></p>
                  </div>
                      <p class="seeall showhide-link"><a href="#" id="morepast-show">4 more...</a></p>
              </dd>
              <dt>Education</dt>
              <dd>
                <ul>
                      <li>
                        
           American Board of Toxicology
      
                      </li>
                      <li>
                        
           The University of Texas at Austin
      
                      </li>
                      <li>
                        
           University of California, Davis
      
                      </li>
                </ul>
                  <div class="showhide-block" id="moreedu">
                    <ul>
                          <li>
                            
           Madras Veterinary College (TNAU)
      
                          </li>
                    </ul>
                    <p class="seeall showhide-link"><a href="#" id="moreedu-hide">see less...</a></p>
                  </div>
                      <p class="seeall showhide-link"><a href="#" id="moreedu-show">1 more...</a></p>
              </dd>
              <dt class="recommended">Recommended</dt>
              <dd class="recommended">
<img src="http://static02.linkedin.com/img/icon/endorse/icon_endorse_1_35x24.gif" width="35" height="24" alt="Sarath has 1 recommendation(s)" title="Sarath has 1 recommendation(s)" />                <strong class="recommendation-count r1">1</strong> person has recommended Sarath </dd>
              <dt class="connections">Connections</dt>
              <dd class="connections">
                <img src="http://static02.linkedin.com/img/icon/conx/icon_conx_16_24x24.gif" width="24" height="24" alt="" />
                <strong class="connection-count">
                308
                </strong> connections
              </dd>

              <dt>Industry</dt>
              <dd>
                Pharmaceuticals
              </dd>
            
          </dl>
        </div>
        <hr />
          <div id="summary">
            <h2>Sarath Kanekal&#8217;s Summary</h2>
              <p class="summary">
                Board certified Toxicologist (DABT).<br>
17 years of  Non-Clinical Pharma Leadership &amp; Consultancy in Biotech/Pharma companies: Toxicology, Pharmacology, Pharmacokinetics, Metabolism and Translational Medicine.<br>
Strategy, design and management of IND- and NDA/BLA-enabling studies.<br>
IND/NDA strategy, authoring and troubleshooting.<br>
Leadership &amp; mentoring of Toxicology/Safety Pharmacology/TK/DMPK and Translational/Clinical Pharmacology groups.<br>
16 INDs and 7 NDA/BLAs (Treanda, Bexxar, Accusite, Omacetaxine, IntraDose etc).<br>
I can answer:<br>
Is your drug worthy of Development? <br>
Can I file an IND? Will it be safe &amp; efficacious in humans (odds of)?<br>
Odds of FDA approval?<br>
How to get approval for 'unapproved' marketed prescription drugs?
              </p>
              <h3>Sarath Kanekal&#8217;s Specialties:</h3>
              <p class="skills">
                Preclinical strategy- animal POC to IND (cPOC)<br>
NCEs, Biologics (Abs,Vaccines &amp; Adjuvants): oncology &amp; dermatology drugs<br>
Approval for 'unapproved marketed' prescription drugs<br>
ClinPharm strategy &amp; PK data analysis.<br>
Toxicology &amp; DMPK issues, go/no-go decisions <br>
Clinical holds- FDA responses &amp; rebuttals.<br>
IND/NDA/BLA strategy and authoring.<br>
Memberships: <br>
Round Table of Tox Consultants<br>
Amer Board of Toxicology<br>
Amer College of Toxicology<br>
Soc of Toxicology<br>
Reg Affairs Prof Society
              </p>
          </div>
          <hr />
          <div id="experience">
            <h2>Sarath Kanekal&#8217;s Experience</h2>
            <ul class="vcalendar">



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      President
    
      </h3>
      <h4 class="org summary">WWW.TOX-CONSULTANT.COM</h4>
  <p class="organization-details">(Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="2009-01-01">January 2009</abbr>
 &mdash; <abbr class="dtstamp" title="2009-11-10">Present</abbr>        <abbr class="duration" title="P11M">(11 months)</abbr>
  </p>
    <p class="description">Drug Development consultancy for Pharma &amp; Biotech companies.<br>
Toxicology, Pharmacology, Drug Metabolism and Pharmacokinetics.<br>
Authoring IND, NDA &amp; BLA documents for US &amp; EU. <br>
GLP toxicology protocols, study placement and monitoring.<br>
Clinical Pharmacology program development and protocol generation.<br>
Strategy for FDA clinical holds and authoring FDA rebuttal letters.</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Executive Director, Preclinical Development
    
      </h3>
      <h4 class="org summary"><a href="http://www.linkedin.com/companies/supergen?trk=ppro_cprof&amp;lnk=vw_cprofile" >SuperGen</a></h4>
  <p class="organization-details">(Public Company; SUPG; Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="2007-02-01">February 2007</abbr>
 &mdash; <abbr class="dtend" title="2009-01-01">January 2009</abbr>        <abbr class="duration" title="P2Y">(2 years )</abbr>
  </p>
    <p class="description">In charge of nonclinical Drug Development: Toxicology, Pharmacology, Drug Metabolism, Pharmacokinetics and Translational Medicine.<br>
Focus: oncology, inflammation and anti-infectives, targeted TKIs.<br>
Clinical Pharmacology support: ClinPharm strategy, BA assay transfer, validation, PK report review &amp; interpretation.<br>
Designed and executed preclinical programs for:<br>
MP470 IND (cMet &amp; Rad51 inhibitor)<br>
SGI-1776 (PIM Kinase).<br>
MP529 IND (Aurora kinase inhibitor)<br>
SGI-1252 (JAK Kinase).<br>
Biomarker PK/PD program development: cells, mouse models and human explants.<br>
Mentored DMPK, Toxicology, Bioanalytical Chemistry and  Translational Pharmacology PhD scientists.<br>
Executed extramural IND-enabling GLP studies at CROs.<br>
Participated in FDA preIND and IND meetings and teleconferences.<br>
Provided Regulatory Strategy for drug development.<br>
Authored IND (CTD format), IB and other Regulatory documents.<br>
Global outsourcing to China &amp; India CROs to save $$ and increase efficiency</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Consultant, Nonclinical
    
      </h3>
      <h4 class="org summary">Chemgenex Inc</h4>
  <p class="organization-details">(Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="2006-09-01">September 2006</abbr>
 &mdash; <abbr class="dtend" title="2007-02-01">February 2007</abbr>        <abbr class="duration" title="P6M">(6 months)</abbr>
  </p>
    <p class="description">Nonclinical (Tox DMPK) and clinical PK program development for Omacetaxine (HHT).<br>
Developed NDA-enabling strategy for both nonclinical (DMPKTOX) &amp; clinical (PK)<br>
Troubleshoot tox issues holding drug development. <br>
IND strategy, authoring &amp; support for both US &amp; EU<br>
Attended FDA meetings- IND &amp; EOPII<br>
Authored FDA rebuttal letters.<br>
Authored &amp; reviewed omacetxaine NDA.</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Toxicology PK consultant
    
      </h3>
      <h4 class="org summary"><a href="http://www.linkedin.com/companies/supergen?trk=ppro_cprof&amp;lnk=vw_cprofile" >SuperGen</a></h4>
  <p class="organization-details">(Public Company; 1-10 employees; SUPG; Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="2006-07-01">July 2006</abbr>
 &mdash; <abbr class="dtend" title="2007-02-01">February 2007</abbr>        <abbr class="duration" title="P8M">(8 months)</abbr>
  </p>
    <p class="description">Nonclinical (Tox DMPK) and clinical consultancy at Supergen.<br>
Troubleshoot tox issues holding drug development.<br>
GLP tox studies monitoring.<br>
IND strategy, authoring &amp; support.<br>
Attended FDA meetings- IND.<br>
Authored FDA rebuttal letters.</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Associate Director, Drug Assesment &amp; Development
    
      </h3>
      <h4 class="org summary">Chiron (Novartis)</h4>
  <p class="organization-details">(Biotechnology industry)</p>
  <p class="period">
        <abbr class="dtstart" title="2005-09-01">September 2005</abbr>
 &mdash; <abbr class="dtend" title="2006-10-01">October 2006</abbr>        <abbr class="duration" title="P1Y2M">(1 year 2 months)</abbr>
  </p>
    <p class="description">Toxicology support for Novartis' (Chiron) global operations: world-wide tox/drug safety support to all Divisions.<br>
Toxicology strategy &amp; assessment for CHIR-265 IND, an oncology TKI product targeting RAF kinase.<br>
Toxicology representative on several project teams.<br>
Monitored extramural and intramural toxicology GLP &amp; non-GLP studies.<br>
Development of toxicology programs for novel immunostimulants (SMIPS).<br>
Special Toxicology programs for immuno modulator drug leads (vaccines &amp; adjuvants).<br>
Toxicology support for Chiron&#x2019;s marketed drug products: PSURs, Annual Reports.<br>
Mentored junior DABT Toxicologists<br>
Toxicology Report writing/editing to support Regulatory filings (FDA &amp; EU).<br>
Authoring sections of- and critical review of IND, IB and other Regulatory documents.<br>
Safety assessment/Toxicology support to commercial manufacturing operations (MSDS etc).</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Senior Director, Pharmacology &amp; Toxicology
    
      </h3>
      <h4 class="org summary">Salmedix Inc (Cephalon)</h4>
  <p class="organization-details">(Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="2002-10-01">October 2002</abbr>
 &mdash; <abbr class="dtend" title="2005-09-01">September 2005</abbr>        <abbr class="duration" title="P3Y">(3 years )</abbr>
  </p>
    <p class="description">Lead the non-clinical development of Bendamustine (Treanda), authored the nonclinical sections of NDA.<br>
Built the Tox/PK group and developed budgets for capital expenditures and labor.<br>
Developed several cancer models (prostate, colon, lymphoma etc) in nude/SCID mice for efficacy screening.<br>
Developed academic research collaborations in US and Europe.<br>
Evaluated in-licensing drugs for efficacy, safety and toxicity to assess probability of clinical success (Fujisawa, Aventis, Vertex, Collgard, Asahi Kasei, Chemgenex, Fortress, ImaRx, Neopharma, SLIL, Heidelberg Pharma etc.)<br>
Prepared out-licensing packages of preclinical stage drug candidates (Aventis, BMS etc.).<br>
Clinical Pharmacology:<br>
Reviewed European clinical PK studies on SDX-105 for the US IND.<br>
Drafted an NDA-enabling clinical PK study plan for FDA EOP2 meeting.<br>
Analyzed clinical PK data using WINNONLIN to support clinical PII trials.<br>
Provided clinical PK expertise and strategic plans at project team meetings.</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Director Drug Safety
    
      </h3>
      <h4 class="org summary">Corixa</h4>
  <p class="organization-details">(Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="2001-09-01">September 2001</abbr>
 &mdash; <abbr class="dtend" title="2002-10-01">October 2002</abbr>        <abbr class="duration" title="P1Y2M">(1 year 2 months)</abbr>
  </p>
    <p class="description">Designed and monitored intra- extra-mural non-GLP/GLP toxicology and PK animal studies on novel immunostimulatory biologics including toll-like receptors, antibodies, antigens, vaccines and adjuvants for a variety of indications to support INDs or Phase-I/II clinical trials. (Lung cancer, Tb, Leishmania vaccine products, Ab+NCE targeted combos such as Super LuDox).<br>
Cancer vaccine development, IND support: NSCLC &amp; Melanoma<br>
In charge of building a Drug Safety Group to conduct Toxicology/Safety studies; developed budgets for capital expenditures and labor.<br>
Lead the nonclinical Drug Safety group spread across two states (CA and MT).<br>
Active participation in project teams, regulatory and clinical groups and interactions with partners (such as Japan Tobacco and Xambone Pharma Italy).<br>
Participation in pre-IND meetings with the FDA and in animal house management meetings ( IACUC).<br>
Retained as Executive Consultant by Corixa Corp.</p>
</li>



<li class="experience vevent vcard"> <a href="#name" class="include"></a>
      <h3 class="title">
        
      Assoc Director, Tox/PK
    
      </h3>
      <h4 class="org summary">Matrix Pharmaceuticals</h4>
  <p class="organization-details">(Pharmaceuticals industry)</p>
  <p class="period">
        <abbr class="dtstart" title="1993-05-01">May 1993</abbr>
 &mdash; <abbr class="dtend" title="2001-08-01">August 2001</abbr>        <abbr class="duration" title="P8Y4M">(8 years 4 months)</abbr>
  </p>
    <p class="description">Toxicology:<br>
Designed and monitored intra- extra-mural non-GLP/GLP toxicology animal studies on oncology and dermal drug products.<br>
Designed and monitored PK/ADME via storage-phosphor autoradiography.<br>
Lead the Tox/PK R&amp;D group. <br>
Developed budgets for capital expenditures and labor.<br>
Generated study reports for Tox/PK studies to support IND, NDA and European regulatory filings (MAA) per ICH guidelines (AccuSiteTM and IntraDoseTM NDAs).<br>
Addressed Tox/Safety/PK issues raised by Regulatory Agencies in US and Europe.<br>
Supervision of Lab Animal facility, establish policies to ensure compliance with State and USDA regulations. <br>
Clinical Pharmacology:<br>
Designed clinical PK phase I/II and NDA-enabling studies of slow release products, (AccuSite and IntraDose NDAs, interferon, and FMdC PII PK trials).<br>
Analyzed and interpreted clinical PK data using WINNONLIN/PCNONLIN.<br>
Authored Regulatory PK reports, documents, and clinical PK manuscripts.<br>
Authored ODAC briefing documents.</p>
</li>
            </ul>
          </div>
          <hr />
          <div id="education">
            <h2>Sarath Kanekal&#8217;s Education</h2>
            <ul class="vcalendar">


	<li class="education vevent vcard">
    <h3 class="summary fn org">
           American Board of Toxicology
      </h3>
		<div class="description">
    <p>
      <span class="degree">DABT</span>
        , 
      <span class="major">Toxicology</span>
      , 
          <abbr class="dtstart" title="1995-01-01">1995</abbr> &mdash; <abbr class="dtend" title="1995-12-31">1995</abbr> 
    </p>
      <p class="notes"></p>
		<dl class="activities-societies">
			<dt>Activities and Societies:</dt>
			<dd>Board Certification in Toxicology</dd>
		</dl>
		</div>
  </li>


	<li class="education vevent vcard">
    <h3 class="summary fn org">
           The University of Texas at Austin
      </h3>
		<div class="description">
    <p>
      <span class="degree">Postdoc</span>
        , 
      <span class="major">Toxicology</span>
      , 
          <abbr class="dtstart" title="1990-01-01">1990</abbr> &mdash; <abbr class="dtend" title="1993-12-31">1993</abbr> 
    </p>
      <p class="notes">Mechanisms of cancer drug toxicity.<br>
American Pharmaceutical Manufacturer Association Scholar, PhRMA</p>
		</div>
  </li>


	<li class="education vevent vcard">
    <h3 class="summary fn org">
           University of California, Davis
      </h3>
		<div class="description">
    <p>
      <span class="degree">PhD</span>
        , 
      <span class="major">Pharmacology &amp; Toxicology</span>
      , 
          <abbr class="dtstart" title="1984-01-01">1984</abbr> &mdash; <abbr class="dtend" title="1990-12-31">1990</abbr> 
    </p>
      <p class="notes">UC Regents Fellow<br>
Thesis Advisors:  Dr. Alan Buckpitt, Dr. Charles Plopper and Dr. Hanspeter Witschi, Dr Bruce Hammock</p>
		<dl class="activities-societies">
			<dt>Activities and Societies:</dt>
			<dd>Member:<br>
ASPET: Pharmacology<br>
SOT: Toxicology<br>
ISSX: Metabolism/Pharmacokinetics</dd>
		</dl>
		</div>
  </li>


	<li class="education vevent vcard">
    <h3 class="summary fn org">
           Madras Veterinary College (TNAU)
      </h3>
		<div class="description">
    <p>
      <span class="degree">BVSC (DVM)</span>
        , 
      <span class="major">Vetrinary Medicine &amp; Surgery</span>
      , 
          <abbr class="dtstart" title="1979-01-01">1979</abbr> &mdash; <abbr class="dtend" title="1984-12-31">1984</abbr> 
    </p>
      <p class="notes">Small animal &amp; large animal medicine &amp; surgery, pets &amp; domestic animals.</p>
		</div>
  </li>
            </ul>
          </div>
          <hr />
          <div id="additional-information">
            <h2>Additional Information</h2>
              <h3>Sarath Kanekal&#8217;s Interests:</h3>
              <p class="interests">Pharmaceutical Toxicology
Drug metabolism &amp; disposition
Regulatory Affairs
Philosophy
Photo/videography</p>
              <h3>Sarath Kanekal&#8217;s Groups:</h3>
                <p class="groups">
                  Roundtable of Toxicology Consultants (RTC)<br>
American Board of Toxicology (ABT)<br>
Society of Toxicology (SOT)<br>
Pharmacology &amp; Experimental Therapeutics (ASPET)<br>
Regulatory Affairs Professionals (RAPS)<br>
American Association of Cancer Research (AACR)<br>
American Association of Pharmaceutical Scientists (AAPS)
                </p>
              <ul>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=2877&amp;sharedKey=30950504D0B7" >          <img src="http://media.linkedin.com/media/p/1/000/000/009/261964b.gif" width="60" height="30" alt="On Startups - The Community For Entrepreneurs" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">On Startups - The Community For Entrepreneurs</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=36798&amp;sharedKey=70943A1BBBDB" >          <img src="http://media.linkedin.com/media/p/3/000/000/2e9/25eda91.png" width="60" height="30" alt="Lifesciences Opportunities in US" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Lifesciences Opportunities in US</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=43683&amp;sharedKey=45B979091531" >          <img src="http://media.linkedin.com/media/p/1/000/002/0ac/3bc6886.png" width="60" height="30" alt="Asia-Pacific Pharmaceutical Industry Professionals" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Asia-Pacific Pharmaceutical Industry Professionals</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=44512&amp;sharedKey=763FBC1E74A5" >          <img src="http://media.linkedin.com/media/p/3/000/002/273/1d28812.png" width="60" height="30" alt="YOUNG INDIAN ENTREPRENEURS" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">YOUNG INDIAN ENTREPRENEURS</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=55993&amp;sharedKey=7E436361F06C" >          <img src="http://media.linkedin.com/media/p/1/000/006/001/0bc0fe1.png" width="60" height="30" alt="BayBiopharma" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">BayBiopharma</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=56509&amp;sharedKey=01F71C3962CC" >          <img src="http://media.linkedin.com/media/p/2/000/005/021/0b829f0.png" width="60" height="30" alt="Regulatory Affairs Info Exchange" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Regulatory Affairs Info Exchange</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=58888&amp;sharedKey=1C49D3285575" >          <img src="http://media.linkedin.com/media/p/1/000/013/19b/0d704bb.png" width="60" height="30" alt="Pharma Connections Worldwide" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Pharma Connections Worldwide</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=60035&amp;sharedKey=378558122A75" >          <img src="http://media.linkedin.com/media/p/1/000/00e/357/24afaec.png" width="60" height="30" alt="Biotech &amp; Pharma Professionals Network" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Biotech &amp; Pharma Professionals Network</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=61852&amp;sharedKey=4A6C9B2DF6EC" >          <img src="http://media.linkedin.com/media/p/1/000/009/095/389a39f.png" width="60" height="30" alt="Professionals in Pharmaceutical Industry and Biotech Industry" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Professionals in Pharmaceutical Industry and Biotech Industry</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=70402&amp;sharedKey=34F6647EC1BF" >          <img src="http://media.linkedin.com/media/p/2/000/00c/24a/2b76f92.png" width="60" height="30" alt="Pharma Business" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Pharma Business</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=75654&amp;sharedKey=03AF8315F083" >          <img src="http://media.linkedin.com/media/p/3/000/006/2ed/0a4b075.png" width="60" height="30" alt="FDA Regulatory -Pharma, BIO, MD&amp;D" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">FDA Regulatory -Pharma, BIO, MD&amp;D</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=80327&amp;sharedKey=3E1A2077C84C" >          <img src="http://media.linkedin.com/media/p/3/000/007/0bb/0770a0f.png" width="60" height="30" alt="Quality &amp; Regulatory Network" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Quality &amp; Regulatory Network</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=97675&amp;sharedKey=26453F5DBCA7" >          <img src="http://media.linkedin.com/media/p/1/000/008/3e6/3548d28.png" width="60" height="30" alt="Drug Safety Executive Council" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Drug Safety Executive Council</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=99549&amp;sharedKey=5A693E3386EF" >          <img src="http://media.linkedin.com/media/p/1/000/009/09f/21cdde2.gif" width="60" height="30" alt="! NRI (NON RESIDENT INDIANs) - Largest and Earliest Platform to Reunite NRIs, PIOs, and OCIs" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">! NRI (NON RESIDENT INDIANs) - Largest and Earliest Platform to Reunite NRIs, PIOs, and OCIs</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=106928&amp;sharedKey=2705C9705554" >          <img src="http://media.linkedin.com/media/p/1/000/009/3af/167f9cd.png" width="60" height="30" alt="The Toxicology Forum" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">The Toxicology Forum</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=110767&amp;sharedKey=30ACD41623C4" >          <img src="http://media.linkedin.com/media/p/2/000/015/262/0eaf434.png" width="60" height="30" alt="Regulatory Affairs Professionals Society (RAPS)" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Regulatory Affairs Professionals Society (RAPS)</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=119050&amp;sharedKey=2D4C86611731" >          <img src="http://media.linkedin.com/media/p/2/000/00a/3c8/35cf818.png" width="60" height="30" alt="Pharmaceutical &amp; Biotech  Licensing &amp; Business Network" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Pharmaceutical &amp; Biotech  Licensing &amp; Business Network</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=120575&amp;sharedKey=747CA7282D83" >          <img src="http://media.linkedin.com/media/p/1/000/00b/04d/24334f3.png" width="60" height="30" alt="Early Stage Clinical Trials" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Early Stage Clinical Trials</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=128293&amp;sharedKey=7C99DE2D8338" >          <img src="http://media.linkedin.com/media/p/1/000/00b/2e6/108b079.png" width="60" height="30" alt="RADSP - Regulatory Affairs &amp; Drug Safety Professionals" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">RADSP - Regulatory Affairs &amp; Drug Safety Professionals</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=135553&amp;sharedKey=618DC10AEC37" >          <img src="http://media.linkedin.com/media/p/2/000/00c/156/35f9cf1.png" width="60" height="30" alt="Cell Therapy Industry group" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Cell Therapy Industry group</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=141799&amp;sharedKey=5D58B077ED9E" >          <img src="http://media.linkedin.com/media/p/1/000/00d/3c8/1dd4f2a.png" width="60" height="30" alt="Biotech Investment Group" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Biotech Investment Group</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=145494&amp;sharedKey=6485B51F65D6" >          <img src="/img/groups/default/default_small.gif" width="60" height="30" alt="Pre-Clinical Forum" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Pre-Clinical Forum</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=165490&amp;sharedKey=31B9CA1D92E1" >          <img src="http://media.linkedin.com/media/p/1/000/025/278/123d3b1.png" width="60" height="30" alt="Drug Discovery &amp; Development Professionals" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Drug Discovery &amp; Development Professionals</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=700687&amp;sharedKey=3F2C0D05098A" >          <img src="http://media.linkedin.com/media/p/1/000/012/0c1/1efa89f.png" width="60" height="30" alt="The Science Advisory Board" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">The Science Advisory Board</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=876387&amp;sharedKey=6EF45A422CA1" >          <img src="http://media.linkedin.com/media/p/3/000/011/1ca/0608a6c.png" width="60" height="30" alt="San Diego Biotechnology Network (SDBN)" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">San Diego Biotechnology Network (SDBN)</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=1008637&amp;sharedKey=3AD7F80DCCAA" >          <img src="http://media.linkedin.com/media/p/2/000/012/3d7/3490e7c.png" width="60" height="30" alt="Oncology Drug Development (1000+ Members)" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Oncology Drug Development (1000+ Members)</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=1797075&amp;sharedKey=32AEF968903D" >          <img src="http://media.linkedin.com/media/p/3/000/01b/3c8/3079e02.png" width="60" height="30" alt="China Pharma Biotech Professional Network" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">China Pharma Biotech Professional Network</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=1810417&amp;sharedKey=0F92856D5361" >          <img src="http://media.linkedin.com/media/p/2/000/01c/332/01e7e69.png" width="60" height="30" alt="The Association of Asian American Professionals in Biotechnology and Pharmaceuticals" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">The Association of Asian American Professionals in Biotechnology and Pharmaceuticals</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=1818190&amp;sharedKey=307F0D04ED6E" >          <img src="http://media.linkedin.com/media/p/3/000/01d/196/02ef706.png" width="60" height="30" alt="BioTech Leaders" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">BioTech Leaders</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=1869205&amp;sharedKey=5A12270E04B8" >          <img src="http://media.linkedin.com/media/p/3/000/020/240/3c43feb.png" width="60" height="30" alt="Contract Research Organizations in Asia-Pacific" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Contract Research Organizations in Asia-Pacific</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=1902169&amp;sharedKey=4C9036191025" >          <img src="http://media.linkedin.com/media/p/3/000/022/19e/17c0165.png" width="60" height="30" alt="Biotech and Pharma Consultants" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">Biotech and Pharma Consultants</span> </li>
                  <li class="affiliation vcard">
                        <a href="http://www.linkedin.com/groupInvitation?groupID=1903117&amp;sharedKey=47244152B41A" >          <img src="http://media.linkedin.com/media/p/2/000/022/227/14b85e8.png" width="60" height="30" alt="BEXXAR Alumni" class="logo" />
</a>&nbsp;&nbsp;
                    <span class="fn org">BEXXAR Alumni</span> </li>
              </ul>
              <h3>Sarath Kanekal&#8217;s Honors:</h3>
              <p class="honors">
                Pharmaceutical Manufacturers' Association Fellow (PhRMA Fellow).<br>
UC Regents Fellow, University of California, Davis<br>
UC Regents Distinguished Scholar, University of California, Davis
              </p>
          </div>
          <hr />
      <div id="contact-settings">
        <h2>Sarath Kanekal&#8217;s Contact Settings</h2>
        <h3>Interested In:</h3>
        <ul>
            <li>
              career opportunities
            </li>
            <li>
              consulting offers
            </li>
            <li>
              new ventures
            </li>
            <li>
              expertise requests
            </li>
            <li>
              reference requests
            </li>
            <li>
              getting back in touch
            </li>
        </ul>
      </div>
      <hr />
      <div class="viewfull">
        <p><a href="http://www.linkedin.com/ppl/webprofile?vmi=&id=13897601&pvs=pp&authToken=iHvk&authType=name&locale=en_US&trk=ppro_viewmore&lnk=vw_pprofile" class="action" rel="nofollow"><span>View Full Profile</span></a></p>
      </div>
  </div>
  <div id="control" class="infobar">
    <div class="powered">
      <h3> Public profile powered by: <a href="/home?trk=ppro_pbli" ><img src="http://static01.linkedin.com/img/logos/logo_82x23.png" height="23" width="82" alt="LinkedIn" /></a>
      </h3>
      <p>Create a public profile: <strong>
        <a href="http://www.linkedin.com/ppl/webprofile?gwp=&id=13897601&pvs=pp&authToken=iHvk&authType=name&locale=en_US&trk=ppro_geturl&lnk=sign_in" rel="nofollow">Sign In</a>
        </strong> or <strong>
        <a href="http://www.linkedin.com/ppl/webprofile?gwp=&id=13897601&pvs=pp&authToken=iHvk&authType=name&locale=en_US&trk=ppro_joinnow&lnk=join_now" rel="nofollow">Join Now</a>
        </strong></p>
    </div>
      <div class="box" id="readmore">
        <div class="title">
          <h3>View Sarath Kanekal&#8217;s full profile:</h3>
        </div>
        <div class="content">
          <ul>
            <li>See who you and <strong>Sarath Kanekal</strong> know in common</li>
            <li>Get introduced to <strong>Sarath Kanekal</strong></li>
            <li>Contact <strong>Sarath Kanekal</strong> directly</li>
          </ul>
          <p class="btn">
            <a href="http://www.linkedin.com/ppl/webprofile?vmi=&id=13897601&pvs=pp&authToken=iHvk&authType=name&locale=en_US&trk=ppro_viewmore&lnk=vw_pprofile" class="action" rel="nofollow"><span>View Full Profile</span></a>
          </p>
        </div>
      </div>
    
    
    <div class="box" id="search">
      <div class="title">
        <h3><strong>Name Search:</strong></h3>
      </div>
      <div class="content">
        <p><strong>Search for people you know</strong> from over 50 million professionals already on LinkedIn.</p>
        <form name="searchForm" action="/pub/dir/" method="get">
          <p class="field"><span class="lbl">
            <label for="first">First Name</label>
            <br />
            </span>
            <input type="text" name="first" id="first" />
            &nbsp;&nbsp;<span class="lbl"><br />
            <label for="last">Last Name</label>
            <br />
            </span>
            <input type="text" name="last" id="last" />
          </p>
          <p class="example">
            <input class="btn-secondary" type="submit" name="search" value="Search"/> (example: <strong>
<a href="http://www.linkedin.com/in/jeffweiner08?trk=ppro_find_others_rh" >Jeff Weiner</a></strong>)
          </p>
        </form>
      </div>
    </div>

    
    <script type="text/javascript">
      var dbl_page = 'public_profile';
    </script>
    
      <script type="text/javascript" src="http://static.linkedin.com/scds/pprofile/build-502_6_2523-prod/js/ads.js"></script>
    
      <script type="text/javascript">
      /* <![CDATA[ */
      var google_keywords = null, google_ad_client = 'pub-2283433109277150', google_ad_width = 300, google_ad_height = 250, google_ad_format = '300x250_as';
        var dbl_src = "http://ad.doubleclick.net/adj/linkedin.dart/" + dbl_page + ";;tile=1;dcopt=ist;sz=300x250;" + encodeURIComponent('extra=null') + ";ord=" + Math.random() * 10000000000000000 +"?";
        document.write('<script src="' + dbl_src + '" type="text/javascript"><\/script>');
      /* ]]> */
      </script>
  </div>
</div>
<hr />







<div id="footer">
  <div class="wrapper">
    <div id="directory">
      <h3>LinkedIn member directory:</h3>
      <ol type="a">
        <li><a href="/directory/people/a.html" >a</a></li>
        <li><a href="/directory/people/b.html" >b</a></li>
        <li><a href="/directory/people/c.html" >c</a></li>
        <li><a href="/directory/people/d.html" >d</a></li>
        <li><a href="/directory/people/e.html" >e</a></li>
        <li><a href="/directory/people/f.html" >f</a></li>
        <li><a href="/directory/people/g.html" >g</a></li>
        <li><a href="/directory/people/h.html" >h</a></li>
        <li><a href="/directory/people/i.html" >i</a></li>
        <li><a href="/directory/people/j.html" >j</a></li>
        <li><a href="/directory/people/k.html" >k</a></li>
        <li><a href="/directory/people/l.html" >l</a></li>
        <li><a href="/directory/people/m.html" >m</a></li>
        <li><a href="/directory/people/n.html" >n</a></li>
        <li><a href="/directory/people/o.html" >o</a></li>
        <li><a href="/directory/people/p.html" >p</a></li>
        <li><a href="/directory/people/q.html" >q</a></li>
        <li><a href="/directory/people/r.html" >r</a></li>
        <li><a href="/directory/people/s.html" >s</a></li>
        <li><a href="/directory/people/t.html" >t</a></li>
        <li><a href="/directory/people/u.html" >u</a></li>
        <li><a href="/directory/people/v.html" >v</a></li>
        <li><a href="/directory/people/w.html" >w</a></li>
        <li><a href="/directory/people/x.html" >x</a></li>
        <li><a href="/directory/people/y.html" >y</a></li>
        <li><a href="/directory/people/z.html" >z</a></li>
        <li type="disc"><a href="/directory/people/@.html" >more</a></li>
      </ol>
      <h3>Browse members</h3>
      <p>
        <a href="/static?key=country_listing" >by country</a>
      </p>
    </div>

    <ul id="nav-legal">
      <li class="first"><a href="/redirect?url=http%3A%2F%2Fpress%2Elinkedin%2Ecom%2Fabout&urlhash=ONnW" >About LinkedIn</a></li>
      <li><a href="/static?key=privacy_policy&trk=hb_ft_priv" >Privacy Policy</a></li>
      
          <li><a href="/redirect?url=http%3A%2F%2Flinkedin%2Ecusthelp%2Ecom&urlhash=M-b0" target="_blank">Customer Service</a></li>
        
      <li><a href="http://talent.linkedin.com/?pin=tr02" >Recruiting Solutions</a></li>
      <li><a href="/static?key=advertising_info&trk=trk%3Dhb_ft_ads" >Advertising</a></li>
    </ul>
    <p id="copyright">Copyright &copy; 2009 LinkedIn Corporation. All rights reserved. </p>
  
    <p id="terms-of-use">
      Use of this site is subject to express <a href="/static?key=user_agreement&trk=ftr_useragre">terms of use</a>, which prohibit commercial use of this site. By continuing past this page, you agree to abide by these terms.
    </p>
  </div>
</div>





  
  
  
  
  
   

        <script type="text/javascript" src="http://static.linkedin.com/scds/concat/pprofile/build-502_6_2523-prod/js?f=lib%2Fyui%2F2.7.0%2Fyahoo-dom-event%2Fyahoo-dom-event&amp;f=js%2Fcore%2FDefine&amp;f=js%2Futil%2FHelps&amp;f=js%2Fpublic_profile&amp;f=js%2Fshowhide&amp;f=js%2Fcookies"></script>
    
<script type="text/javascript">
/* <![CDATA[ */
  if(typeof(i18n) == 'undefined') var i18n = {}; 
  i18n.TEXT_PLEASE_ENTER = "Please enter a first and last name.";
  showHide.init();

  var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
  document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
/* ]]> */
</script>
<script type="text/javascript">
/* <![CDATA[ */
var pageTracker = _gat._getTracker("UA-3242811-1");
pageTracker._initData();
pageTracker._linkedInMemberCookie = readCookie("visit"); 
pageTracker._linkedInUserType = (pageTracker._linkedInMemberCookie == "M") ? "user" : "guest";  
pageTracker._setVar(pageTracker._linkedInUserType);
    pageTracker._trackPageview("control_profiles");    
/* ]]> */
</script>


<script type="text/javascript" src="http://edge.quantserve.com/quant.js"></script> 
<noscript> 
  <a href="http://www.quantcast.com/p-b3sGjMtCFrexE" target="_blank"><img src="http://pixel.quantserve.com/pixel/p-b3sGjMtCFrexE.gif" style="display: none;" border="0" height="1" width="1" alt="Quantcast" /></a> 
</noscript>



<script type="text/javascript" src="http://b.scorecardresearch.com/beacon.js"></script> 
<script type="text/javascript">
  COMSCORE.beacon({ c1:2, c2:6402952, c3:"", c4:"", c5:"", c6:"", c15:"" });
</script>
<noscript> 
  <img src="http://b.scorecardresearch.com/b?c1=2&amp;c2=6402952&amp;c3=&amp;c4=&amp;c5=&amp;c6=&amp;c15=&amp;cv=1.3&amp;cj=1" style="display:none" width="0" height="0" alt="" />
</noscript>



</body>
</html>

